Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
about
Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencingGenetic testing for RAD51C mutations: in the clinic and communityConnecting molecular pathways to hereditary cancer risk syndromesTherapy-related myeloid neoplasms: pathobiology and clinical characteristicsActivation of mutant enzyme function in vivo by proteasome inhibitors and treatments that induce Hsp70A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.Clinical and molecular characterization of the BRCA2 p.Asn3124Ile variant reveals substantial evidence for pathogenic significance.Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized MedicineImpact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors.Brain tumors in Li-Fraumeni syndrome: a commentary and a case of a gliosarcoma patient.Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care.The dichotomy of p53 regulation by noncoding RNAs.TP53 mutations in human cancers: origins, consequences, and clinical useClinical outcomes and correlates of TP53 mutations and cancer.Fibrosarcoma of the eyelid in two sibling Czech wolfdogs.Prevalence of the TP53 p.R337H mutation in breast cancer patients in BrazilClinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessmentBaseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls.Hereditary pancreatic cancer: related syndromes and clinical perspective.Peripheral primitive neuroectodermal tumor of the dura in a 51-year-old woman following intensive treatment for breast cancerAdrenocortical carcinoma and synchronous malignancies.Clinical management of hereditary breast cancer syndromes.Anaplastic rhabdomyosarcoma in TP53 germline mutation carriersTranslational advances regarding hereditary breast cancer syndromes.Late onset Li-Fraumeni Syndrome with bilateral breast cancer and other malignancies: case report and review of the literature.Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.10 rare tumors that warrant a genetics referral.Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndromeNext-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes.Evaluation of the carcinogenicity of inorganic arsenic.Increased oxidative damage in carriers of the germline TP53 p.R337H mutationHereditary ovarian cancer: not only BRCA 1 and 2 genes.Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.Inherited germline TP53 mutation encodes a protein with an aberrant C-terminal motif in a case of pediatric adrenocortical tumorSarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database.Rare and unusual endocrine cancer syndromes with mutated genes.Inherited predisposition to breast cancer among African American women.Breast cancer in young womenTP53-Associated Pediatric Malignancies.Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML.
P2860
Q24606803-2E4E9898-DB90-4582-902F-26139E6490B9Q28253197-C3F1B546-AFCA-46D4-9578-6769CB347D17Q28291516-009A1B07-F8A8-46B1-9812-F9F7484454EDQ28386366-9EB552A6-74D3-4F57-94D9-9C637221F409Q28472376-AD4FF993-C3E2-4E16-80AB-8E2F6F425DC3Q30252766-0C5CC5DA-4F33-4C9D-AC3C-1F8BB4D35F0DQ30361333-421630CB-1DBF-4BF0-AD3E-5447151BD497Q30513982-ED6CCFD2-3FED-413E-BC99-893371BCA6F5Q30554353-7BF89389-0D01-4A00-8B72-B3245D60A37EQ31121646-1E742541-CDF5-42B9-93C5-C41367A20D67Q33493584-6180E98A-4BBA-4C49-829B-8B829B2F7E0EQ33668469-856BE4AB-263E-4D03-971F-52767F003839Q33685392-AEE86B53-5726-4477-9334-DBA71DF7AB31Q33693838-2CA10B14-D189-4C95-B1CB-EE18D3A8FAC2Q33715799-98B0C28E-230E-402C-ACAA-850F262B5C04Q33768942-2BF019F6-5BE7-4DF9-B638-A4516B1D84F8Q33796155-049B157F-00A0-4D6F-896E-2BCE1B27A490Q33844055-535C6C14-EB98-4BC8-A5FD-84E638EFAE41Q33851085-9FAA27F4-8C49-416A-9FFB-EBE8C5924BE8Q33916661-B0E0EDB5-002A-4B77-B2A7-650C0BA8F55BQ34121984-84DBCD56-296C-47ED-A82B-8EA029FF81EFQ34167563-B1B3C5FF-A1F2-4BAB-B992-5D84D0F4C29EQ34235576-2BAB0595-3A61-4076-96E2-C29B4C22E57BQ34263162-021CF1B5-D0D6-4EF4-8473-1BEEE3663211Q34294432-88EBBBAB-D0BF-4718-BADD-8E76845EBC84Q34324683-8D795945-1166-4147-B55D-3FA092CF0434Q34325954-A9AF7863-D1F7-4B8D-9405-A339D15D1798Q34335864-3F7F128D-721E-45F3-87A7-82F4622523F1Q34356721-954BACB5-2DB6-406D-9B33-B09F007D9DE2Q34371580-85DE78D8-9A87-40A7-8D2F-0CD8CC915518Q34442664-4346F12B-DC0A-4406-ABE9-204157FD02F8Q34480707-E21BEF72-BBFF-4A02-9957-7AE6B77F627DQ34550417-BB5F8D54-2612-4014-B810-DBFAA4D83D2FQ34565153-2C7D328D-8C72-4204-B370-4DF8F88729D9Q34631589-46105E7A-9563-4848-9A44-DF1F9AA5349FQ34645240-2A0FCC1D-ED6F-4079-A843-1DFFCFD43EE3Q34983596-67A112F7-49C6-4C1C-87CE-7188448C78E7Q34989073-8996965E-47CC-4187-BD07-D6C0C757C875Q35103165-CF1D4357-A2D8-40EE-867D-CFFCB247DD83Q35205646-0D3102FD-5099-4AEE-A182-90054C6AC624
P2860
Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Beyond Li Fraumeni Syndrome: c ...... s with p53 germline mutations.
@en
Beyond Li Fraumeni Syndrome: c ...... s with p53 germline mutations.
@nl
type
label
Beyond Li Fraumeni Syndrome: c ...... s with p53 germline mutations.
@en
Beyond Li Fraumeni Syndrome: c ...... s with p53 germline mutations.
@nl
prefLabel
Beyond Li Fraumeni Syndrome: c ...... s with p53 germline mutations.
@en
Beyond Li Fraumeni Syndrome: c ...... s with p53 germline mutations.
@nl
P2093
P50
P356
P1476
Beyond Li Fraumeni Syndrome: c ...... s with p53 germline mutations.
@en
P2093
Carolyn H Buzin
Cindy Y Wen-Fong
Dongqing Gu
Jennifer H Han
Katie A Noltner
Katrina Lowstuter
Steve S Sommer
Vu Q Nguyen
P304
P356
10.1200/JCO.2008.16.6959
P407
P577
2009-02-09T00:00:00Z